List of insiders holdings for Protara Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Opaleye L.P. 10% Owner | 2020-01-13 18:48:29 | 2,208,472 0 | 2,208,472 | Form 4 |
| Freund John Gordon Director | 2019-11-12 17:00:27 | 2,175,882 354 | 2,176,236 | Form 4 |
| Haines Timothy Former Director and 10% Owner Director | 2019-11-14 16:14:05 | 0 2,146,917 | 2,146,917 | Form 4 |
| TVM Life Science Ventures VI GmbH & Co KG Fischer Stefan Goll Alexandra SCHUHSLER HELMUT TVM Life Science Ventures VI LP 10% Owner | 2017-08-02 17:13:17 | 1,943,059 0 | 1,943,059 | Form 13D |
| TVM Life Science Ventures VI GmbH & Co KG TVM Life Science Ventures VI LP Birner Hubert Fischer Stefan SCHUHSLER HELMUT Director 10% Owner | 2017-08-02 17:13:17 | 1,943,059 0 | 1,943,059 | Form 13D |
| Opaleye Management Inc. 10% Owner | 2024-11-18 06:01:42 | 1,681,154 0 | 1,681,154 | Form 13G |
| Skyline Venture Partners Qualified Purchaser Fund IV L P Skyline Venture Management IV LLC Freund John Gordon KANEKO YASUNORI 10% Owner | 2014-11-03 16:55:58 | 1,432,930 0 | 1,432,930 | Form 13D |
| Prism Venture Partners V L P Prism Venture Partners V-A LP 10% Owner | 2015-02-24 15:40:03 | 1,337,462 0 | 1,337,462 | Form 13G |
| Pharmstandard International S.A. Public Joint Stock Co Pharmstandard 10% Owner | 2015-02-12 14:40:06 | 1,165,344 0 | 1,165,344 | Form 13G |
| Shefferman Jesse CEO and President | 2024-08-30 16:05:11 | 935,501 0 | 935,501 | Form 4 |
| Marshall Randall Former 10% Owner | 2020-09-15 18:04:24 | 585,600 0 | 585,600 | Form 4 |
| NOYES TIMOTHY P President and CEO | 2019-02-04 08:00:34 | 350,000 0 | 350,000 | Form 4 |
| Zummo Jacqueline Chf Scientific Operations Off | 2024-01-23 16:05:26 | 241,296 0 | 241,296 | Form 4 |
| Bandari Jathin Chief Medical Officer | 2024-01-23 16:05:30 | 193,704 0 | 193,704 | Form 4 |
| Fabbio Patrick Chief Financial Officer | 2024-01-23 16:05:22 | 153,000 0 | 153,000 | Form 4 |
| Eldridge George Arthur Sr VP, CFO, Treasr, Asst Secy | 2019-01-23 16:18:40 | 145,000 0 | 145,000 | Form 4 |
| Burke Steven Keith SVP and Chief Medical Officer | 2019-03-18 08:15:41 | 101,917 26,332 | 128,249 | Form 4 |
| Abingworth LLP Former 10% Owner | 2020-01-17 16:09:45 | 113,920 0 | 113,920 | Form 13D |
| Casoy Julio Chief Medical Officer | 2020-01-13 19:09:46 | 83,651 0 | 83,651 | Form 4 |
| Fry Hannah VP, Controller | 2024-01-23 16:05:19 | 75,836 0 | 75,836 | Form 4 |
| Hartman Bradley J VP, People | 2019-01-23 16:19:14 | 70,000 0 | 70,000 | Form 4 |
| Kowalsky Matthew Paul VP, Legal and Secretary | 2019-01-23 16:19:47 | 60,000 0 | 60,000 | Form 4 |
| Toner E. Scott Senior VP of Commercial | 2019-01-23 16:20:20 | 60,000 0 | 60,000 | Form 4 |
| Gottlieb Daniel Philip VP Corporate Development | 2019-01-23 16:20:55 | 60,000 0 | 60,000 | Form 4 |
| Davis Blaine Chief Financial Officer | 2022-07-19 16:31:18 | 20,662 0 | 20,662 | Form 4 |
| Olivo Martin Sebastian Chief Medical Officer | 2021-06-14 17:52:26 | 14,344 0 | 14,344 | Form 4 |
| Birner Hubert Director 10% Owner | 2018-06-11 16:31:02 | 12,700 0 | 12,700 | Form 4 |
| Canute Scott A Director | 2018-06-11 16:31:49 | 12,700 0 | 12,700 | Form 4 |
| LEFF JONATHAN S Director | 2018-06-12 14:45:12 | 12,700 0 | 12,700 | Form 4 |
| BOHLIN GAREN G Director | 2018-06-11 16:31:24 | 12,700 0 | 12,700 | Form 4 |
| Kingsley Stuart A Director | 2018-06-11 16:34:14 | 12,700 0 | 12,700 | Form 4 |
| HASTINGS PAUL J Director | 2018-06-11 16:33:31 | 12,700 0 | 12,700 | Form 4 |
| Smith Cynthia Director | 2024-06-10 18:00:25 | 10,000 0 | 10,000 | Form 4 |
| Levy Richard S Director | 2024-06-10 18:00:18 | 10,000 0 | 10,000 | Form 4 |
| Huang Jane Director | 2024-06-10 18:00:15 | 10,000 0 | 10,000 | Form 4 |
| BESHAR LUKE M Director | 2024-06-10 18:00:10 | 10,000 0 | 10,000 | Form 4 |
| GARCEAU ROGER Director | 2024-06-10 18:00:12 | 10,000 0 | 10,000 | Form 4 |
| SARGEN GREGORY Director | 2024-06-10 18:00:20 | 10,000 0 | 10,000 | Form 4 |
| Solomon Michael Edward Director | 2024-06-10 18:00:23 | 10,000 0 | 10,000 | Form 4 |
| Flannelly Barry P Director | 2024-06-10 18:00:31 | 10,000 0 | 10,000 | Form 4 |
| Braunstein Scott Director | 2020-06-11 13:33:56 | 9,000 0 | 9,000 | Form 4 |
| PHELPS GREGORY D Director | 2015-06-03 13:03:48 | 6,666 0 | 6,666 | Form 4 |
| Kobyzev Dmitry Director 10% Owner | 2015-06-03 12:34:48 | 6,666 0 | 6,666 | Form 4 |
| O'Leary Brendan Director | 2016-06-14 16:35:27 | 6,666 0 | 6,666 | Form 4 |
| Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund L.P. Deerfield Special Situations International Master Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Possible Member of 10% Group 10% Owner | 2021-01-08 15:32:30 | 0 0 | 0 | Form 13D |
| Flynn James E Deerfield Private Design Fund III L.P. Deerfield Special Situations Fund L.P. Deerfield International Master Fund L.P. DEERFIELD PARTNERS L.P. Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. Deerfield Mgmt III L.P. Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT CO *Director by Deputization Director | 2021-01-08 15:32:30 | 0 0 | 0 | Form 13D |
| Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) *Director by Deputization Director | 2021-01-08 15:32:30 | 0 0 | 0 | Form 13D |
| Flynn James E DEERFIELD MANAGEMENT CO Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Deerfield International Master Fund L.P. *Director by Deputization Director | 2021-01-08 15:32:30 | 0 0 | 0 | Form 13D |